ERBB2 and cancer: Furthermore, consistent with our study, AKT inhibitors and HER2 inhibitors have also been reported to increase radiotherapy sensitivity in a variety of cancers.[33, 50, 51] However, inhibitors targeting RNF126 have not been developed.